+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Blood Glucose Test Strips Market - Global Forecast 2026-2032- Product Image
Blood Glucose Test Strips Market - Global Forecast 2026-2032- Product Image
Sale

Blood Glucose Test Strips Market - Global Forecast 2026-2032

  • Report

  • 185 Pages
  • August 2026
  • Region: Global
  • 360iResearch™
  • ID: 6010976
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Blood Glucose Test Strips Market is projected to reach USD 3.26 Billion in 2026. It is expected to continue growing at a CAGR of 7.79%, reaching USD 5.13 Billion by 2032.

Blood glucose test strips remain a critical consumable in diabetes management because they support routine self-monitoring of blood glucose, therapy adjustment, and hypoglycemia prevention for insulin users and many people with type 2 diabetes. The International Diabetes Federation reported 537 million adults living with diabetes in 2021 and projected the total to reach 643 million by 2030, creating a durable base of demand for accurate, affordable, and widely available testing supplies.

The market is shaped by the clinical need for reliable capillary blood testing, payer scrutiny over recurring consumable costs, and the growing use of connected glucose meters. Although continuous glucose monitoring adoption is expanding, blood glucose test strips remain essential for many patients due to affordability, prescription coverage patterns, calibration or confirmation needs, and access gaps in low- and middle-income settings.

Transformative Shifts in the Test Strip Landscape

The blood glucose test strips landscape is shifting from basic consumable supply toward integrated diabetes care. Product differentiation increasingly centers on improved electrochemical strip chemistry, smaller blood sample requirements, faster read times, interference resistance, and meter-strip systems aligned with ISO 15197 accuracy expectations.

At the same time, reimbursement pressure and competitive tendering are compressing prices in mature markets, while emerging economies continue to prioritize affordability and distribution reach. Connected meters, mobile apps, e-pharmacy channels, and home-based chronic disease management are changing purchasing behavior and creating new opportunities for recurring patient engagement.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is influencing the blood glucose test strips ecosystem through the devices, software, and operations connected to strip-based testing. AI-enabled applications can interpret glucose logs, flag potential hypoglycemia or hyperglycemia patterns, support adherence reminders, and help clinicians prioritize patients who need intervention.

The cumulative impact is also operational. Manufacturers can use machine vision for strip defect detection, predictive analytics for demand planning, and AI-supported quality systems to reduce variability in high-volume production. AI does not replace test strips; instead, it increases the value of each reading by converting episodic glucose measurements into more actionable diabetes insights.

Key Regional Insights Across Major Markets

Asia-Pacific is central to blood glucose test strip demand because it includes China and India, two of the world’s largest diabetes populations according to International Diabetes Federation estimates, while Japan, South Korea, and Australia sustain usage through aging populations, established care pathways, and strong quality expectations. North America remains a high-value market due to strong diagnosis rates, pharmacy access, and payer coverage, with the CDC reporting 38.4 million people with diabetes in the United States and a large population requiring regular glucose monitoring.

Europe is shaped by mature reimbursement systems, strict medical device regulation, and growing home-care adoption, with clinical guidelines continuing to support self-monitoring for insulin-treated patients and selected non-insulin users. Latin America, led by Brazil and Mexico, combines expanding chronic disease awareness with affordability constraints and uneven access across urban and rural areas. The Middle East shows elevated diabetes prevalence in several Gulf markets, supporting premium connected testing solutions and preventive-care initiatives, while Africa presents long-term need as diagnosis rates, primary care capacity, and access to affordable testing supplies improve.

Key Group Insights for Strategic Positioning

ASEAN markets are expanding as urbanization, dietary shifts, and broader pharmacy networks increase the need for accessible diabetes monitoring, particularly in Indonesia, Thailand, Vietnam, Malaysia, and the Philippines. The GCC is distinguished by high diabetes prevalence, strong healthcare investment, and rising interest in connected home-monitoring tools that support prevention programs, chronic disease management, and patient engagement.

The European Union prioritizes CE-marked quality, compliance with the Medical Device Regulation, data protection requirements for connected meters, and reimbursement discipline. BRICS countries represent scale, with China, India, Brazil, Russia, and South Africa combining large patient pools with varied affordability, procurement, and distribution challenges. G7 markets favor clinically validated, digitally connected meter-strip systems supported by strong pharmacy channels and prescriber familiarity, while NATO countries increasingly view medical supply continuity, diagnostics availability, and resilient procurement as part of healthcare preparedness planning.

Key Country Insights for Blood Glucose Test Strips

The United States is driven by large diagnosed and prediabetes populations, retail pharmacy reach, and insurer formulary decisions, with CDC data indicating 38.4 million people with diabetes and 97.6 million adults with prediabetes. Canada benefits from established primary care and provincial coverage variation, while Mexico and Brazil offer demand through private pharmacy channels, public screening initiatives, and growing diabetes awareness. In Europe, the United Kingdom, Germany, France, Italy, and Spain have mature treatment pathways, with Germany and France emphasizing reimbursement controls, the United Kingdom focusing on NHS value and evidence-based prescribing, and Italy and Spain balancing regional procurement with broad patient access.

Russia remains a scale market with regional access variation and ongoing need for reliable diabetes supplies. China and India are the largest volume opportunities due to population size and diabetes burden, but price sensitivity, regional reimbursement differences, and distribution reach remain significant. Japan, Australia, and South Korea are advanced markets where aging demographics, digital health adoption, and quality expectations support demand for reliable meter-strip platforms, while South Korea and Japan also show strong acceptance of connected health tools and structured chronic disease management.

Actionable Recommendations for Industry Leaders

Industry leaders should balance affordability, accuracy, and digital integration. Competitive advantage will come from ISO-aligned performance, consistent lot quality, broad meter compatibility strategies where appropriate, and evidence demonstrating usability across patient populations, including older adults and people with limited health literacy.

Companies should strengthen pharmacy, e-commerce, and institutional distribution while tailoring pack sizes and price points to local reimbursement realities. Investment in connected meters, AI-supported apps, clinician dashboards, and patient education can increase adherence and retention. Leaders should also build resilient supply chains for enzymes, electrodes, substrates, packaging, and electronics to reduce disruption risk and improve continuity of patient access.

Research Methodology

This executive summary is developed using a secondary-research framework grounded in verified public sources, including the International Diabetes Federation, CDC, WHO, regulatory guidance, standards references, peer-reviewed diabetes literature, and government health statistics. Insights are cross-checked for consistency across epidemiology, regulation, reimbursement, technology adoption, and healthcare access indicators.

The methodology evaluates demand drivers, regional healthcare access, competitive differentiation, digital health trends, and supply-chain considerations. Findings are presented qualitatively where reliable market-size figures are not universally comparable across sources, ensuring that conclusions remain evidence-based and suitable for strategic decision-making without relying on market estimation, market sizing, market share, or market forecasting.

Conclusion

Blood glucose test strips continue to play a foundational role in global diabetes care despite rapid innovation in continuous glucose monitoring. Their relevance is anchored in affordability, clinical familiarity, pharmacy availability, and the need for dependable point-in-time glucose confirmation.

Future advantage will be strongest for organizations that combine validated strip accuracy with connected ecosystems, AI-enabled insights, resilient manufacturing, and localized access strategies. As diabetes prevalence rises globally, test strips will remain an essential component of patient-centered glucose monitoring and routine chronic disease management.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Blood Glucose Test Strips Market, by Technology
7.1. Introduction
7.2. Electrochemical
7.3. Enzymatic
7.3.1. Glucose Oxidase (GOD)
7.3.2. Glucose Dehydrogenase (GDH)
7.4. Mediator Technology
8. Blood Glucose Test Strips Market, by Component
8.1. Introduction
8.2. Biological Enzymes
8.3. Conductive Materials (Electrode Materials)
8.3.1. Gold
8.3.2. Carbon
8.3.3. Platinum
8.4. Polymers (Stip Base)
8.4.1. Polyester
8.4.2. Polyethylene Terephthalate (PET)
8.5. Chemicals Reagents
8.5.1. Mediators
8.5.2. Stabilizers
8.5.3. Buffers
9. Blood Glucose Test Strips Market, by Indication
9.1. Introduction
9.2. Type 1 Diabetes
9.3. Type 2 Diabetes
9.4. Gestational Diabetes
9.5. Prediabetes & At-Risk Monitoring
10. Blood Glucose Test Strips Market, by Packing Type
10.1. Introduction
10.2. Vial-Pack
10.3. Individually Foil-Wrapped
10.4. Cartridge-Loaded
10.5. Drum-Loaded
11. Blood Glucose Test Strips Market, by End User
11.1. Introduction
11.2. Self-Care Consumers
11.3. Hospitals
11.4. Clinics & Physician Offices
11.5. Home Healthcare Providers
12. Blood Glucose Test Strips Market, by Distribution Channel
12.1. Introduction
12.2. Offline
12.2.1. Department Stores
12.2.2. Specialty Stores
12.3. Online
12.3.1. Company Websites
12.3.2. E-commerce Platforms
13. Blood Glucose Test Strips Market, by Region
13.1. North America
13.2. Asia-Pacific
13.3. Europe
13.4. Latin America
13.5. Middle East
13.6. Africa
14. Blood Glucose Test Strips Market, by Group
14.1. NATO
14.2. G7
14.3. BRICS
14.4. European Union
14.5. ASEAN
14.6. GCC
15. Blood Glucose Test Strips Market, by Country
15.1. United States
15.2. China
15.3. Germany
15.4. Canada
15.5. India
15.6. United Kingdom
15.7. South Korea
15.8. Mexico
15.9. Japan
15.10. Russia
15.11. Brazil
15.12. Italy
15.13. Spain
15.14. France
15.15. Australia
16. Competitive Landscape
16.1. Market Share Analysis, 2025
16.2. FPNV Positioning Matrix, 2025
16.3. Market Concentration Analysis, 2025
16.3.1. Concentration Ratio (CR)
16.3.2. Herfindahl Hirschman Index (HHI)
16.4. Recent Developments & Impact Analysis, 2025
16.5. Product Portfolio Analysis, 2025
16.6. Benchmarking Analysis, 2025
17. Company Profiles
17.1. Abbott Laboratories
17.2. F. Hoffmann-La Roche Ltd.
17.3. Sanofi S.A.
17.4. LifeScan IP Holdings, LLC
17.5. Nipro Corporation
17.6. Terumo Corporation
17.7. i-SENS, Inc.
17.8. Nova Biomedical Corporation
17.9. Ascensia Diabetes Care Holdings AG
17.10. Trividia Health, Inc.
17.11. B. Braun Melsungen AG
17.12. 77 Elektronika Kft.
17.13. Bioland Technology Ltd.
17.14. Sinocare Inc.
17.15. Rossmax International Ltd.
17.16. Bionime Corporation
17.17. TaiDoc Technology Corporation
17.18. OK Biotech Co., Ltd.
17.19. EKF Diagnostics Holdings plc
17.20. A. Menarini Diagnostics srl
17.21. DarioHealth Corp.
17.22. HMD Biomedical Inc.
17.23. Morepen Laboratories Limited
17.24. ARKRAY, Inc.
17.25. Alliance International Co., Ltd.
17.26. GlucoRx Limited
17.27. Hangzhou Lysun Biotechnology Co., Ltd.
17.28. OSANG HEALTHCARE Co., Ltd.
17.29. Prodigy Diabetes Care, LLC
17.30. Sejoy Biomedical Co., Ltd.
List of Figures
FIGURE 1. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, 2024-2032 (USD MILLION)
FIGURE 6. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2025 VS 2032 (%)
FIGURE 7. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY COMPONENT, 2025 VS 2032 (%)
FIGURE 9. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY COMPONENT, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY INDICATION, 2025 VS 2032 (%)
FIGURE 11. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY INDICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY PACKING TYPE, 2025 VS 2032 (%)
FIGURE 13. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY PACKING TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 15. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2032 (%)
FIGURE 17. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 19. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 21. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 23. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 24. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 25. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
List of Tables
TABLE 1. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 3. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 4. GLOBAL ELECTROCHEMICAL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 5. GLOBAL ELECTROCHEMICAL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 6. GLOBAL ELECTROCHEMICAL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 7. GLOBAL ENZYMATIC MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 8. GLOBAL ENZYMATIC MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 9. GLOBAL ENZYMATIC MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 10. GLOBAL GLUCOSE OXIDASE (GOD) MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 11. GLOBAL GLUCOSE OXIDASE (GOD) MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 12. GLOBAL GLUCOSE OXIDASE (GOD) MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 13. GLOBAL GLUCOSE DEHYDROGENASE (GDH) MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 14. GLOBAL GLUCOSE DEHYDROGENASE (GDH) MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 15. GLOBAL GLUCOSE DEHYDROGENASE (GDH) MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 16. GLOBAL MEDIATOR TECHNOLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 17. GLOBAL MEDIATOR TECHNOLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 18. GLOBAL MEDIATOR TECHNOLOGY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 19. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY COMPONENT, 2017-2032 (USD MILLION)
TABLE 20. GLOBAL BIOLOGICAL ENZYMES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 21. GLOBAL BIOLOGICAL ENZYMES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 22. GLOBAL BIOLOGICAL ENZYMES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 23. GLOBAL CONDUCTIVE MATERIALS (ELECTRODE MATERIALS) MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 24. GLOBAL CONDUCTIVE MATERIALS (ELECTRODE MATERIALS) MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 25. GLOBAL CONDUCTIVE MATERIALS (ELECTRODE MATERIALS) MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 26. GLOBAL GOLD MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 27. GLOBAL GOLD MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 28. GLOBAL GOLD MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 29. GLOBAL CARBON MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 30. GLOBAL CARBON MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 31. GLOBAL CARBON MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 32. GLOBAL PLATINUM MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 33. GLOBAL PLATINUM MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 34. GLOBAL PLATINUM MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 35. GLOBAL POLYMERS (STIP BASE) MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 36. GLOBAL POLYMERS (STIP BASE) MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 37. GLOBAL POLYMERS (STIP BASE) MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 38. GLOBAL POLYESTER MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 39. GLOBAL POLYESTER MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 40. GLOBAL POLYESTER MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 41. GLOBAL POLYETHYLENE TEREPHTHALATE (PET) MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 42. GLOBAL POLYETHYLENE TEREPHTHALATE (PET) MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 43. GLOBAL POLYETHYLENE TEREPHTHALATE (PET) MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 44. GLOBAL CHEMICALS REAGENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 45. GLOBAL CHEMICALS REAGENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 46. GLOBAL CHEMICALS REAGENTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 47. GLOBAL MEDIATORS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 48. GLOBAL MEDIATORS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 49. GLOBAL MEDIATORS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 50. GLOBAL STABILIZERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 51. GLOBAL STABILIZERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 52. GLOBAL STABILIZERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 53. GLOBAL BUFFERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 54. GLOBAL BUFFERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 55. GLOBAL BUFFERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 56. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 57. GLOBAL TYPE 1 DIABETES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 58. GLOBAL TYPE 1 DIABETES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 59. GLOBAL TYPE 1 DIABETES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 60. GLOBAL TYPE 2 DIABETES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 61. GLOBAL TYPE 2 DIABETES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 62. GLOBAL TYPE 2 DIABETES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 63. GLOBAL GESTATIONAL DIABETES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 64. GLOBAL GESTATIONAL DIABETES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 65. GLOBAL GESTATIONAL DIABETES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 66. GLOBAL PREDIABETES & AT-RISK MONITORING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 67. GLOBAL PREDIABETES & AT-RISK MONITORING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 68. GLOBAL PREDIABETES & AT-RISK MONITORING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 69. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY PACKING TYPE, 2017-2032 (USD MILLION)
TABLE 70. GLOBAL VIAL-PACK MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 71. GLOBAL VIAL-PACK MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 72. GLOBAL VIAL-PACK MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 73. GLOBAL INDIVIDUALLY FOIL-WRAPPED MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 74. GLOBAL INDIVIDUALLY FOIL-WRAPPED MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 75. GLOBAL INDIVIDUALLY FOIL-WRAPPED MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 76. GLOBAL CARTRIDGE-LOADED MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 77. GLOBAL CARTRIDGE-LOADED MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 78. GLOBAL CARTRIDGE-LOADED MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 79. GLOBAL DRUM-LOADED MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 80. GLOBAL DRUM-LOADED MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 81. GLOBAL DRUM-LOADED MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 82. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 83. GLOBAL SELF-CARE CONSUMERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 84. GLOBAL SELF-CARE CONSUMERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 85. GLOBAL SELF-CARE CONSUMERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 86. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 87. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 88. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 89. GLOBAL CLINICS & PHYSICIAN OFFICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 90. GLOBAL CLINICS & PHYSICIAN OFFICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 91. GLOBAL CLINICS & PHYSICIAN OFFICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 92. GLOBAL HOME HEALTHCARE PROVIDERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 93. GLOBAL HOME HEALTHCARE PROVIDERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 94. GLOBAL HOME HEALTHCARE PROVIDERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 95. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 96. GLOBAL OFFLINE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 97. GLOBAL OFFLINE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 98. GLOBAL OFFLINE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 99. GLOBAL DEPARTMENT STORES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 100. GLOBAL DEPARTMENT STORES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 101. GLOBAL DEPARTMENT STORES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 102. GLOBAL SPECIALTY STORES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 103. GLOBAL SPECIALTY STORES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 104. GLOBAL SPECIALTY STORES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 105. GLOBAL ONLINE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 106. GLOBAL ONLINE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 107. GLOBAL ONLINE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 108. GLOBAL COMPANY WEBSITES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 109. GLOBAL COMPANY WEBSITES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 110. GLOBAL COMPANY WEBSITES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 111. GLOBAL E-COMMERCE PLATFORMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 112. GLOBAL E-COMMERCE PLATFORMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 113. GLOBAL E-COMMERCE PLATFORMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 114. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 115. NORTH AMERICA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 116. NORTH AMERICA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 117. NORTH AMERICA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY ENZYMATIC, 2017-2032 (USD MILLION)
TABLE 118. NORTH AMERICA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY COMPONENT, 2017-2032 (USD MILLION)
TABLE 119. NORTH AMERICA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY CONDUCTIVE MATERIALS (ELECTRODE MATERIALS), 2017-2032 (USD MILLION)
TABLE 120. NORTH AMERICA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY POLYMERS (STIP BASE), 2017-2032 (USD MILLION)
TABLE 121. NORTH AMERICA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY CHEMICALS REAGENTS, 2017-2032 (USD MILLION)
TABLE 122. NORTH AMERICA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 123. NORTH AMERICA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY PACKING TYPE, 2017-2032 (USD MILLION)
TABLE 124. NORTH AMERICA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 125. NORTH AMERICA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 126. NORTH AMERICA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY OFFLINE, 2017-2032 (USD MILLION)
TABLE 127. NORTH AMERICA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY ONLINE, 2017-2032 (USD MILLION)
TABLE 128. ASIA-PACIFIC BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 129. ASIA-PACIFIC BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 130. ASIA-PACIFIC BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY ENZYMATIC, 2017-2032 (USD MILLION)
TABLE 131. ASIA-PACIFIC BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY COMPONENT, 2017-2032 (USD MILLION)
TABLE 132. ASIA-PACIFIC BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY CONDUCTIVE MATERIALS (ELECTRODE MATERIALS), 2017-2032 (USD MILLION)
TABLE 133. ASIA-PACIFIC BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY POLYMERS (STIP BASE), 2017-2032 (USD MILLION)
TABLE 134. ASIA-PACIFIC BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY CHEMICALS REAGENTS, 2017-2032 (USD MILLION)
TABLE 135. ASIA-PACIFIC BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 136. ASIA-PACIFIC BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY PACKING TYPE, 2017-2032 (USD MILLION)
TABLE 137. ASIA-PACIFIC BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 138. ASIA-PACIFIC BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 139. ASIA-PACIFIC BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY OFFLINE, 2017-2032 (USD MILLION)
TABLE 140. ASIA-PACIFIC BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY ONLINE, 2017-2032 (USD MILLION)
TABLE 141. EUROPE BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 142. EUROPE BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 143. EUROPE BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY ENZYMATIC, 2017-2032 (USD MILLION)
TABLE 144. EUROPE BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY COMPONENT, 2017-2032 (USD MILLION)
TABLE 145. EUROPE BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY CONDUCTIVE MATERIALS (ELECTRODE MATERIALS), 2017-2032 (USD MILLION)
TABLE 146. EUROPE BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY POLYMERS (STIP BASE), 2017-2032 (USD MILLION)
TABLE 147. EUROPE BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY CHEMICALS REAGENTS, 2017-2032 (USD MILLION)
TABLE 148. EUROPE BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 149. EUROPE BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY PACKING TYPE, 2017-2032 (USD MILLION)
TABLE 150. EUROPE BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 151. EUROPE BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 152. EUROPE BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY OFFLINE, 2017-2032 (USD MILLION)
TABLE 153. EUROPE BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY ONLINE, 2017-2032 (USD MILLION)
TABLE 154. LATIN AMERICA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 155. LATIN AMERICA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 156. LATIN AMERICA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY ENZYMATIC, 2017-2032 (USD MILLION)
TABLE 157. LATIN AMERICA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY COMPONENT, 2017-2032 (USD MILLION)
TABLE 158. LATIN AMERICA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY CONDUCTIVE MATERIALS (ELECTRODE MATERIALS), 2017-2032 (USD MILLION)
TABLE 159. LATIN AMERICA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY POLYMERS (STIP BASE), 2017-2032 (USD MILLION)
TABLE 160. LATIN AMERICA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY CHEMICALS REAGENTS, 2017-2032 (USD MILLION)
TABLE 161. LATIN AMERICA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 162. LATIN AMERICA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY PACKING TYPE, 2017-2032 (USD MILLION)
TABLE 163. LATIN AMERICA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 164. LATIN AMERICA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 165. LATIN AMERICA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY OFFLINE, 2017-2032 (USD MILLION)
TABLE 166. LATIN AMERICA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY ONLINE, 2017-2032 (USD MILLION)
TABLE 167. MIDDLE EAST BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 168. MIDDLE EAST BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 169. MIDDLE EAST BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY ENZYMATIC, 2017-2032 (USD MILLION)
TABLE 170. MIDDLE EAST BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY COMPONENT, 2017-2032 (USD MILLION)
TABLE 171. MIDDLE EAST BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY CONDUCTIVE MATERIALS (ELECTRODE MATERIALS), 2017-2032 (USD MILLION)
TABLE 172. MIDDLE EAST BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY POLYMERS (STIP BASE), 2017-2032 (USD MILLION)
TABLE 173. MIDDLE EAST BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY CHEMICALS REAGENTS, 2017-2032 (USD MILLION)
TABLE 174. MIDDLE EAST BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 175. MIDDLE EAST BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY PACKING TYPE, 2017-2032 (USD MILLION)
TABLE 176. MIDDLE EAST BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 177. MIDDLE EAST BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 178. MIDDLE EAST BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY OFFLINE, 2017-2032 (USD MILLION)
TABLE 179. MIDDLE EAST BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY ONLINE, 2017-2032 (USD MILLION)
TABLE 180. AFRICA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 181. AFRICA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 182. AFRICA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY ENZYMATIC, 2017-2032 (USD MILLION)
TABLE 183. AFRICA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY COMPONENT, 2017-2032 (USD MILLION)
TABLE 184. AFRICA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY CONDUCTIVE MATERIALS (ELECTRODE MATERIALS), 2017-2032 (USD MILLION)
TABLE 185. AFRICA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY POLYMERS (STIP BASE), 2017-2032 (USD MILLION)
TABLE 186. AFRICA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY CHEMICALS REAGENTS, 2017-2032 (USD MILLION)
TABLE 187. AFRICA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 188. AFRICA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY PACKING TYPE, 2017-2032 (USD MILLION)
TABLE 189. AFRICA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 190. AFRICA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 191. AFRICA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY OFFLINE, 2017-2032 (USD MILLION)
TABLE 192. AFRICA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY ONLINE, 2017-2032 (USD MILLION)
TABLE 193. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 194. NATO BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 195. NATO BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 196. NATO BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY ENZYMATIC, 2017-2032 (USD MILLION)
TABLE 197. NATO BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY COMPONENT, 2017-2032 (USD MILLION)
TABLE 198. NATO BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY CONDUCTIVE MATERIALS (ELECTRODE MATERIALS), 2017-2032 (USD MILLION)
TABLE 199. NATO BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY POLYMERS (STIP BASE), 2017-2032 (USD MILLION)
TABLE 200. NATO BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY CHEMICALS REAGENTS, 2017-2032 (USD MILLION)
TABLE 201. NATO BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 202. NATO BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY PACKING TYPE, 2017-2032 (USD MILLION)
TABLE 203. NATO BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 204. NATO BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 205. NATO BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY OFFLINE, 2017-2032 (USD MILLION)
TABLE 206. NATO BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY ONLINE, 2017-2032 (USD MILLION)
TABLE 207. G7 BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 208. G7 BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 209. G7 BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY ENZYMATIC, 2017-2032 (USD MILLION)
TABLE 210. G7 BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY COMPONENT, 2017-2032 (USD MILLION)
TABLE 211. G7 BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY CONDUCTIVE MATERIALS (ELECTRODE MATERIALS), 2017-2032 (USD MILLION)
TABLE 212. G7 BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY POLYMERS (STIP BASE), 2017-2032 (USD MILLION)
TABLE 213. G7 BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY CHEMICALS REAGENTS, 2017-2032 (USD MILLION)
TABLE 214. G7 BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 215. G7 BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY PACKING TYPE, 2017-2032 (USD MILLION)
TABLE 216. G7 BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 217. G7 BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 218. G7 BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY OFFLINE, 2017-2032 (USD MILLION)
TABLE 219. G7 BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY ONLINE, 2017-2032 (USD MILLION)
TABLE 220. BRICS BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 221. BRICS BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 222. BRICS BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY ENZYMATIC, 2017-2032 (USD MILLION)
TABLE 223. BRICS BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY COMPONENT, 2017-2032 (USD MILLION)
TABLE 224. BRICS BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY CONDUCTIVE MATERIALS (ELECTRODE MATERIALS), 2017-2032 (USD MILLION)
TABLE 225. BRICS BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY POLYMERS (STIP BASE), 2017-2032 (USD MILLION)
TABLE 226. BRICS BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY CHEMICALS REAGENTS, 2017-2032 (USD MILLION)
TABLE 227. BRICS BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 228. BRICS BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY PACKING TYPE, 2017-2032 (USD MILLION)
TABLE 229. BRICS BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 230. BRICS BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 231. BRICS BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY OFFLINE, 2017-2032 (USD MILLION)
TABLE 232. BRICS BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY ONLINE, 2017-2032 (USD MILLION)
TABLE 233. EUROPEAN UNION BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 234. EUROPEAN UNION BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 235. EUROPEAN UNION BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY ENZYMATIC, 2017-2032 (USD MILLION)
TABLE 236. EUROPEAN UNION BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY COMPONENT, 2017-2032 (USD MILLION)
TABLE 237. EUROPEAN UNION BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY CONDUCTIVE MATERIALS (ELECTRODE MATERIALS), 2017-2032 (USD MILLION)
TABLE 238. EUROPEAN UNION BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY POLYMERS (STIP BASE), 2017-2032 (USD MILLION)
TABLE 239. EUROPEAN UNION BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY CHEMICALS REAGENTS, 2017-2032 (USD MILLION)
TABLE 240. EUROPEAN UNION BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 241. EUROPEAN UNION BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY PACKING TYPE, 2017-2032 (USD MILLION)
TABLE 242. EUROPEAN UNION BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 243. EUROPEAN UNION BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 244. EUROPEAN UNION BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY OFFLINE, 2017-2032 (USD MILLION)
TABLE 245. EUROPEAN UNION BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY ONLINE, 2017-2032 (USD MILLION)
TABLE 246. ASEAN BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 247. ASEAN BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 248. ASEAN BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY ENZYMATIC, 2017-2032 (USD MILLION)
TABLE 249. ASEAN BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY COMPONENT, 2017-2032 (USD MILLION)
TABLE 250. ASEAN BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY CONDUCTIVE MATERIALS (ELECTRODE MATERIALS), 2017-2032 (USD MILLION)
TABLE 251. ASEAN BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY POLYMERS (STIP BASE), 2017-2032 (USD MILLION)
TABLE 252. ASEAN BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY CHEMICALS REAGENTS, 2017-2032 (USD MILLION)
TABLE 253. ASEAN BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 254. ASEAN BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY PACKING TYPE, 2017-2032 (USD MILLION)
TABLE 255. ASEAN BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 256. ASEAN BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 257. ASEAN BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY OFFLINE, 2017-2032 (USD MILLION)
TABLE 258. ASEAN BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY ONLINE, 2017-2032 (USD MILLION)
TABLE 259. GCC BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 260. GCC BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 261. GCC BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY ENZYMATIC, 2017-2032 (USD MILLION)
TABLE 262. GCC BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY COMPONENT, 2017-2032 (USD MILLION)
TABLE 263. GCC BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY CONDUCTIVE MATERIALS (ELECTRODE MATERIALS), 2017-2032 (USD MILLION)
TABLE 264. GCC BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY POLYMERS (STIP BASE), 2017-2032 (USD MILLION)
TABLE 265. GCC BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY CHEMICALS REAGENTS, 2017-2032 (USD MILLION)
TABLE 266. GCC BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 267. GCC BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY PACKING TYPE, 2017-2032 (USD MILLION)
TABLE 268. GCC BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 269. GCC BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 270. GCC BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY OFFLINE, 2017-2032 (USD MILLION)
TABLE 271. GCC BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY ONLINE, 2017-2032 (USD MILLION)
TABLE 272. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 273. UNITED STATES BLOOD GLUCOSE TEST STRIPS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 274. UNITED STATES BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 275. UNITED STATES BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY ENZYMATIC, 2017-2032 (USD MILLION)
TABLE 276. UNITED STATES BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY COMPONENT, 2017-2032 (USD MILLION)
TABLE 277. UNITED STATES BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY CONDUCTIVE MATERIALS (ELECTRODE MATERIALS), 2017-2032 (USD MILLION)
TABLE 278. UNITED STATES BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY POLYMERS (STIP BASE), 2017-2032 (USD MILLION)
TABLE 279. UNITED STATES BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY CHEMICALS REAGENTS, 2017-2032 (USD MILLION)
TABLE 280. UNITED STATES BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 281. UNITED STATES BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY PACKING TYPE, 2017-2032 (USD MILLION)
TABLE 282. UNITED STATES BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 283. UNITED STATES BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 284. UNITED STATES BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY OFFLINE, 2017-2032 (USD MILLION)
TABLE 285. UNITED STATES BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY ONLINE, 2017-2032 (USD MILLION)
TABLE 286. CHINA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 287. CHINA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 288. CHINA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY ENZYMATIC, 2017-2032 (USD MILLION)
TABLE 289. CHINA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY COMPONENT, 2017-2032 (USD MILLION)
TABLE 290. CHINA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY CONDUCTIVE MATERIALS (ELECTRODE MATERIALS), 2017-2032 (USD MILLION)
TABLE 291. CHINA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY POLYMERS (STIP BASE), 2017-2032 (USD MILLION)
TABLE 292. CHINA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY CHEMICALS REAGENTS, 2017-2032 (USD MILLION)
TABLE 293. CHINA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 294. CHINA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY PACKING TYPE, 2017-2032 (USD MILLION)
TABLE 295. CHINA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 296. CHINA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 297. CHINA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY OFFLINE, 2017-2032 (USD MILLION)
TABLE 298. CHINA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY ONLINE, 2017-2032 (USD MILLION)
TABLE 299. GERMANY BLOOD GLUCOSE TEST STRIPS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 300. GERMANY BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 301. GERMANY BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY ENZYMATIC, 2017-2032 (USD MILLION)
TABLE 302. GERMANY BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY COMPONENT, 2017-2032 (USD MILLION)
TABLE 303. GERMANY BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY CONDUCTIVE MATERIALS (ELECTRODE MATERIALS), 2017-2032 (USD MILLION)
TABLE 304. GERMANY BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY POLYMERS (STIP BASE), 2017-2032 (USD MILLION)
TABLE 305. GERMANY BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY CHEMICALS REAGENTS, 2017-2032 (USD MILLION)
TABLE 306. GERMANY BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 307. GERMANY BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY PACKING TYPE, 2017-2032 (USD MILLION)
TABLE 308. GERMANY BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 309. GERMANY BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 310. GERMANY BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY OFFLINE, 2017-2032 (USD MILLION)
TABLE 311. GERMANY BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY ONLINE, 2017-2032 (USD MILLION)
TABLE 312. CANADA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 313. CANADA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 314. CANADA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY ENZYMATIC, 2017-2032 (USD MILLION)
TABLE 315. CANADA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY COMPONENT, 2017-2032 (USD MILLION)
TABLE 316. CANADA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY CONDUCTIVE MATERIALS (ELECTRODE MATERIALS), 2017-2032 (USD MILLION)
TABLE 317. CANADA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY POLYMERS (STIP BASE), 2017-2032 (USD MILLION)
TABLE 318. CANADA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY CHEMICALS REAGENTS, 2017-2032 (USD MILLION)
TABLE 319. CANADA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 320. CANADA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY PACKING TYPE, 2017-2032 (USD MILLION)
TABLE 321. CANADA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 322. CANADA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 323. CANADA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY OFFLINE, 2017-2032 (USD MILLION)
TABLE 324. CANADA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY ONLINE, 2017-2032 (USD MILLION)
TABLE 325. INDIA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 326. INDIA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 327. INDIA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY ENZYMATIC, 2017-2032 (USD MILLION)
TABLE 328. INDIA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY COMPONENT, 2017-2032 (USD MILLION)
TABLE 329. INDIA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY CONDUCTIVE MATERIALS (ELECTRODE MATERIALS), 2017-2032 (USD MILLION)
TABLE 330. INDIA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY POLYMERS (STIP BASE), 2017-2032 (USD MILLION)
TABLE 331. INDIA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY CHEMICALS REAGENTS, 2017-2032 (USD MILLION)
TABLE 332. INDIA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 333. INDIA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY PACKING TYPE, 2017-2032 (USD MILLION)
TABLE 334. INDIA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 335. INDIA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 336. INDIA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY OFFLINE, 2017-2032 (USD MILLION)
TABLE 337. INDIA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY ONLINE, 2017-2032 (USD MILLION)
TABLE 338. UNITED KINGDOM BLOOD GLUCOSE TEST STRIPS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 339. UNITED KINGDOM BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 340. UNITED KINGDOM BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY ENZYMATIC, 2017-2032 (USD MILLION)
TABLE 341. UNITED KINGDOM BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY COMPONENT, 2017-2032 (USD MILLION)
TABLE 342. UNITED KINGDOM BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY CONDUCTIVE MATERIALS (ELECTRODE MATERIALS), 2017-2032 (USD MILLION)
TABLE 343. UNITED KINGDOM BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY POLYMERS (STIP BASE), 2017-2032 (USD MILLION)
TABLE 344. UNITED KINGDOM BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY CHEMICALS REAGENTS, 2017-2032 (USD MILLION)
TA

Companies Mentioned

  • Abbott Laboratories
  • F. Hoffmann-La Roche Ltd.
  • Sanofi S.A.
  • LifeScan IP Holdings, LLC
  • Nipro Corporation
  • Terumo Corporation
  • i-SENS, Inc.
  • Nova Biomedical Corporation
  • Ascensia Diabetes Care Holdings AG
  • Trividia Health, Inc.
  • B. Braun Melsungen AG
  • 77 Elektronika Kft.
  • Bioland Technology Ltd.
  • Sinocare Inc.
  • Rossmax International Ltd.
  • Bionime Corporation
  • TaiDoc Technology Corporation
  • OK Biotech Co., Ltd.
  • EKF Diagnostics Holdings plc
  • A. Menarini Diagnostics srl
  • DarioHealth Corp.
  • HMD Biomedical Inc.
  • Morepen Laboratories Limited
  • ARKRAY, Inc.
  • Alliance International Co., Ltd.
  • GlucoRx Limited
  • Hangzhou Lysun Biotechnology Co., Ltd.
  • OSANG HEALTHCARE Co., Ltd.
  • Prodigy Diabetes Care, LLC
  • Sejoy Biomedical Co., Ltd.

Table Information

Report AttributeDetails
No. of Pages185
PublishedAugust 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 3.26 Billion
Forecasted Market Value ( USD ) by 2032 $ 5.13 Billion
Compound Annual Growth Rate7.7%
Regions CoveredGlobal
No. of Companies Mentioned30

Related Topics

Related Reports

Blood Glucose Testing Market - Global Forecast 2026-2032 - Product Image

Blood Glucose Testing Market - Global Forecast 2026-2032

  • Report
  • 196 Pages
  • Global
From
Blood Glucose Test Strips - Global Strategic Business Report - Product Image

Blood Glucose Test Strips - Global Strategic Business Report

  • Report
  • 282 Pages
  • Global
From
Blood Glucose Test Strips Market Report by Type, Technology, Distribution Channel, End User, and Region 2026-2034 - Product Image

Blood Glucose Test Strips Market Report by Type, Technology, Distribution Channel, End User, and Region 2026-2034

  • Report
  • 138 Pages
  • Global
From
Blood Glucose Test Strips - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Image

Blood Glucose Test Strips - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • 105 Pages
  • Global
From
Blood Glucose Test Strips Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031 - Product Image

Blood Glucose Test Strips Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031

  • Report
  • 181 Pages
  • Global
From

About the Blood Glucose Test Strip Market

The Blood Glucose Test Strip market is a segment of the Medical Devices industry. It is composed of products used to measure the amount of glucose in a person's blood. These test strips are used in conjunction with a glucometer, a device that reads the test strip and displays the glucose level. The test strips are typically disposable and are used to monitor and manage diabetes. The market is driven by the increasing prevalence of diabetes, as well as the need for accurate and reliable glucose monitoring. Additionally, technological advancements in test strip design have enabled more accurate readings and improved patient outcomes. Some companies in the Blood Glucose Test Strip market include Abbott Laboratories, Roche Diagnostics, LifeScan, Ascensia Diabetes Care, and B. Braun Melsungen AG. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.